Metagenomic Analysis of Gut Microbiota for Abdominal Aortic Aneurysm
Overview
Authors
Affiliations
The pathophysiological mechanism of abdominal aortic aneurysm (AAA) remains unclear. We previously reported that levels were reduced in the feces of patients with AAA by 16S ribosomal ribonucleic acid (RNA) gene sequencing. In this study, we increased the number of cases and conducted metagenomic analyses to examine bacterial genes associated with the pathophysiology of AAA. For gut microbiota data, feces from 55 patients with AAA and 52 patients with no history of AAA, lower extremity artery disease, or coronary artery disease (control group) were collected. Metagenomic analysis was performed by collecting raw stool samples from patients. For intestinal microbiota analysis, metagenomic analysis of the fecal samples was performed. Oral bacteria, including ( <0.0001), ( <0.001), ( <0.001), and sp. ( <0.001), were increased in the feces of patients with AAA. In addition, bacterial genes related to alpha lipoic acid (ALA) biosynthesis (M00882, M00883, and M00884, <0.0001) were decreased in patients with AAA. In the feces of patients with AAA, there was an increase in oral bacteria, and the expression of bacterial genes related to ALA biosynthesis was reduced. The results suggest the possibility of developing gut microbial drug treatments for AAA.
Molecular Insights into Cardiovascular Disease: Unraveling Pathways for Diagnosis and Treatment.
Yamanouchi D Int J Mol Sci. 2025; 26(5).
PMID: 40076691 PMC: 11900358. DOI: 10.3390/ijms26052067.